Potent Antagonism between Estrogens and Androgens on GCDFP-15 Expression and Cell Growth in the ZR-75-1 Human Breast Cancer Cells
- 1 May 1990
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 586 (1) , 174-187
- https://doi.org/10.1111/j.1749-6632.1990.tb17805.x
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Fluoxymesterone stimulation of tumor marker secretion in patients with breast carcinomaBreast Cancer Research and Treatment, 1986
- In Vitro Modulation of Prolactin Binding to Human Mammary Carcinoma Cells by Steroid Hormones and Prolactin*Journal of Clinical Endocrinology & Metabolism, 1985
- Onset of androgen action in MCF-7 human breast cancer cells is not accompanied by receptor depletionThe Journal of Steroid Biochemistry and Molecular Biology, 1985
- An Antiestrogenic Action of Androgens in Human Breast Cancer Cells*Journal of Clinical Endocrinology & Metabolism, 1981
- Calusterone (7β,17α-DimethyItestosterone) as Primary and Secondary Therapy of Advanced Breast CancerOncology, 1973
- Cystic disease of the breast: Relationship to carcinomaCancer, 1964
- Testosterone Propionate Therapy in Breast CancerJAMA, 1964
- Fluoxymesterone Therapy in Advanced Breast CancerNew England Journal of Medicine, 1958
- Hormonal therapy in cancer of the breast.I. The effect of testosterone propionate therapy on clinical course and hormonal excretionCancer, 1951
- Treatment of Breast Cancer with Testosterone PropionateJournal of Clinical Endocrinology & Metabolism, 1944